HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jamie E Craig Selected Research

ibopamine

4/2016Ibopamine challenge testing becomes negative following successful trabeculectomy surgery.
12/2015Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
5/2014Ibopamine challenge test can be used to differentiate glaucoma suspects from glaucoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jamie E Craig Research Topics

Disease

40Glaucoma
07/2022 - 03/2002
22Open-Angle Glaucoma (Glaucoma, Open Angle)
07/2022 - 02/2003
18Cataract (Cataracts)
01/2021 - 07/2007
14Diabetic Retinopathy (Retinopathy, Diabetic)
06/2020 - 09/2009
8Exfoliation Syndrome
01/2022 - 03/2008
4Type 2 Diabetes Mellitus (MODY)
02/2022 - 09/2009
4Keratoconus
01/2021 - 10/2011
4Ganglion Cysts (Ganglion)
01/2021 - 01/2013
4Angle-Closure Glaucoma (Glaucoma, Angle Closure)
03/2013 - 01/2004
3Blindness (Hysterical Blindness)
12/2019 - 09/2010
3Fuchs' Endothelial Dystrophy
11/2019 - 06/2012
3Diabetes Complications
01/2019 - 05/2012
3Macular Degeneration (Age-Related Maculopathy)
01/2019 - 05/2008
3Diabetes Mellitus
08/2016 - 09/2015
3Nance-Horan syndrome
01/2012 - 06/2006
2Genetic Risk Score
07/2022 - 01/2020
2Macular Edema
04/2022 - 02/2022
2Myopia
01/2019 - 01/2004
2Refractive Errors (Refractive Error)
01/2018 - 11/2008
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 10/2002
2Iron Overload
03/2017 - 07/2007
2hereditary Hyperferritinemia with congenital cataracts
03/2017 - 07/2007
2Inflammation (Inflammations)
01/2016 - 06/2014
2Graves Disease (Basedow Disease)
01/2016 - 06/2014
2Ocular Hypertension (Glaucoma, Suspect)
12/2015 - 01/2012
2Low Tension Glaucoma
01/2015 - 10/2002
2Familial Exudative Vitreoretinopathies
12/2010 - 04/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Granuloma
01/2022
1Pupil Disorders (Marcus Gunn Pupil)
01/2022
1Giant Cell Arteritis (Horton Disease)
01/2022
1Vasculitis (Vasculitides)
01/2022
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2022
1Hypertension (High Blood Pressure)
01/2021
1Amyloid Plaque
01/2021
1Amyloidosis
01/2021
1Intellectual Disability (Idiocy)
01/2021
1Hereditary Corneal Dystrophies
01/2020
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Retinal Detachment (Retinal Detachments)
01/2020
1Pain (Aches)
12/2019

Drug/Important Bio-Agent (IBA)

22trabecular meshwork-induced glucocorticoid response proteinIBA
01/2020 - 03/2002
18Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2006
12Retinaldehyde (Retinal)IBA
01/2022 - 04/2004
7DNA (Deoxyribonucleic Acid)IBA
11/2021 - 12/2003
5Crystallins (Crystallin)IBA
10/2017 - 01/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 09/2009
3Insulin (Novolin)FDA Link
02/2022 - 09/2015
3Biological ProductsIBA
01/2021 - 01/2016
3Pharmaceutical PreparationsIBA
01/2021 - 06/2014
3EphrinsIBA
11/2019 - 05/2009
3ApolipoproteinsIBA
11/2019 - 10/2002
3Capsules (Microcapsules)IBA
01/2018 - 09/2010
3ibopamineIBA
04/2016 - 05/2014
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2012
2CollagenIBA
01/2021 - 01/2018
2Complement Factor H (Factor H)IBA
01/2019 - 05/2008
2Ferritins (Ferritin)IBA
03/2017 - 07/2007
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
04/2013 - 03/2008
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
05/2012 - 03/2010
2Arginine (L-Arginine)FDA Link
04/2012 - 11/2009
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2011 - 01/2011
2Aldehyde Reductase (Aldose Reductase)IBA
08/2010 - 09/2009
2Protein Isoforms (Isoforms)IBA
01/2008 - 10/2002
1Biomarkers (Surrogate Marker)IBA
04/2022
1atezolizumabIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022
1Fluorescein (Funduscein)FDA LinkGeneric
01/2022
1B7-H1 AntigenIBA
01/2022
1Indicators and Reagents (Reagents)IBA
09/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1CholesterolIBA
01/2021
1GelsolinIBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
01/2021
1MorpholinosIBA
01/2021
1Long Noncoding RNAIBA
01/2021
1CateninsIBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021
1CalciumIBA
01/2021
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2020
1NucleotidesIBA
01/2020
1Apolipoproteins E (ApoE)IBA
11/2019
1Immunoglobulins (Immunoglobulin)IBA
11/2019

Therapy/Procedure

6Therapeutics
04/2022 - 05/2004
4Trabeculectomy (Trabeculoplasty)
07/2022 - 01/2012
3Glycemic Control
06/2020 - 09/2015
3Lasers (Laser)
01/2020 - 12/2009
3Vitrectomy
01/2019 - 01/2018
2Lenses
01/2021 - 11/2019
2Intravitreal Injections
12/2019 - 06/2014
2Corneal Transplantation (Keratoplasty)
11/2019 - 11/2008
1Injections
04/2022
1Immunotherapy
01/2022
1Anesthesia
12/2020
1Phacoemulsification
01/2020
1Penetrating Keratoplasty
01/2020
1Stents
01/2020
1Keratectomy
01/2020